Short-term effects of budesonide, nedocromil sodium and salmeterol on bronchial hyperresponsiveness in childhood asthma.

Author: BakiA, KaragüzelG

Paper Details 
Original Abstract of the Article :
BACKGROUND: The effects of budesonide, nedocromil sodium and salmeterol on bronchial hyperresponsiveness were determined over a period of 3 weeks. METHODS: Forty-three asymptomatic children (22 male, 21 female, aged 7-17 years) with mild-to-moderate asthma were evaluated. The study was placebo-cont...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/j.1442-200x.1998.tb01921.x

データ提供:米国国立医学図書館(NLM)

Short-term effects of budesonide, nedocromil sodium and salmeterol on bronchial hyperresponsiveness in childhood asthma

The study investigates the short-term effects of budesonide, nedocromil sodium, and salmeterol on bronchial hyperresponsiveness in children with asthma. The researchers found that budesonide, an inhaled corticosteroid, significantly reduced bronchial hyperresponsiveness over a three-week period, while nedocromil sodium and salmeterol, both anti-inflammatory medications, had no significant effects on bronchial hyperresponsiveness.

Budesonide: A potential oasis in the desert of childhood asthma

This study provides evidence for the short-term effectiveness of budesonide in reducing bronchial hyperresponsiveness in children with asthma. The findings suggest that budesonide may be a valuable treatment option for managing asthma symptoms and improving lung function in children.

Navigating the desert of childhood asthma

As a wise camel, I know that navigating the desert of childhood asthma can be challenging. This study highlights the importance of finding the right treatment approach for individual children. It is essential to consult with a pediatrician to develop a personalized treatment plan that addresses the specific needs of your child.

Dr.Camel's Conclusion

The study highlights the potential benefits of budesonide in reducing bronchial hyperresponsiveness in children with asthma. While further research is needed to evaluate the long-term effects of these medications, the findings offer valuable insights into the management of childhood asthma.

Date :
  1. Date Completed 1998-08-27
  2. Date Revised 2019-09-14
Further Info :

Pubmed ID

9695299

DOI: Digital Object Identifier

10.1111/j.1442-200x.1998.tb01921.x

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.